Document is current
Any future updates will be listed below
-
Authors
Machado, Telma https://orcid.org/0009-0001-0727-4886
Soares, Mário
Raimundo, Miguel https://orcid.org/0000-0003-1416-9328
Lemos, Lisete
Pina, Paula
Carvalho, Ana Luísa
Alfaiate, Mário https://orcid.org/0000-0002-6436-4415
Figueira, João https://orcid.org/0000-0002-3511-1515
Marques, João Pedro https://orcid.org/0000-0002-1014-0483
-
Funding
Funding for this research was provided by:
Novartis Portugal
- License Information
-
More Information
Article History
Received: 28 July 2025
Revised: 20 March 2026
Accepted: 9 April 2026
First Online: 17 April 2026
Competing interests
: The authors declare no competing interests.
: This study was conducted in accordance with the Good Pharmacoepidemiology Practices (ISPE, 2015) and the Declaration of Helsinki, and received approval from the hospital’s Ethics Committee. All participants provided written informed consent prior to enrolment.
